Clinical Trials
All Clinical Trials - Page 62 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01712893Phase 3Completed
Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer
Gonadorelin
- NCT00946920Phase 3Completed
A Trial of Degarelix in Patients With Prostate Cancer
Gonadorelin
- NCT00931372Phase 1Completed
Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2
Lixisenatide
- NCT00826228Phase 4Completed
Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
Teriparatide
- NCT00926380Phase 2Completed
Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
Teriparatide
- NCT01048086Phase 2Withdrawn
90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
Octreotide
- NCT00902057Phase 4Unknown
Desmopressin for Bleeding Related to Low Body Temperature
Desmopressin
- NCT01994330Phase 4Completed
Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Desmopressin
- NCT00928434Phase 3Completed
A Study of Degarelix in Patients With Prostate Cancer
Gonadorelin
- NCT00903162Phase 2Completed
Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
Gonadorelin
- NCT00912548Phase 3Unknown
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women
Gonadorelin
- NCT00766857Phase 4Completed
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
Exenatide
- NCT00886626Phase 2Completed
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
Exenatide
- NCT00905255Phase 3Completed
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
Lixisenatide
- NCT00853723Phase 2Completed
Comparison Study of PTHrP and PTH to Treat Osteoporosis
Teriparatide
- NCT00987168Phase 2Completed
Sandostatine® LP and Hyperinsulinism
Octreotide
- NCT00774930Phase 3Completed
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
Lanreotide
- NCT00833248Phase 3Completed
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Gonadorelin
- NCT00894322Phase 1/Phase 2Completed
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
Exenatide
- NCT00732147N/AWithdrawn
Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
Pramlintide
- NCT00887354Phase 4Completed
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Teriparatide
- NCT00856609Phase 3Completed
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
Exenatide
- NCT00860158Phase 2Terminated
Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
Gonadorelin
- NCT00873223Phase 1Completed
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
Liraglutide
- NCT00856986Phase 3Completed
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
Liraglutide
- NCT00882050Phase 1/Phase 2Completed
Intravenous Exenatide (Byetta) During Surgery
Exenatide
- NCT00870194Phase 4Completed
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
Exenatide
- NCT00877890Phase 3Completed
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
Exenatide
- NCT01381484Phase 3Completed
Argireline in Treatment of Periorbital Wrinkles
Argireline
- NCT00866658Phase 3Completed
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
Lixisenatide
- NCT00891553N/ACompleted
CR9112792, a Follow-up of Study CR9108963
Teriparatide
- NCT00853047Phase 2Completed
Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy
Octreotide
- NCT00885924Phase 4Terminated
Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery
Desmopressin
- NCT00833716Phase 1Completed
Effect of Renal Impairment on the Pharmacokinetics of NN9535
Semaglutide
- NCT00851773Phase 1Completed
Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
Semaglutide
- NCT00795210N/ACompleted
Effects of Short-term Growth Hormone in HIV-infected Patients
Tesamorelin
- NCT00850564N/ACompleted
Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men
Tesamorelin
- NCT00921492N/ACompleted
Acupuncture and Gonadotropin-releasing Hormone Pulse Generator and Stress Axis in Polycystic Ovary Syndrome
Gonadorelin
- NCT02090673N/ACompleted
Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
Exenatide
- NCT00872378Phase 2/Phase 3Unknown
The Effects of Exenatide After Gastric Restriction
Exenatide
- NCT01798264Phase 1Completed
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
Exenatide
- NCT00744224N/ACompleted
PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
Exenatide
- NCT00781911Phase 2Completed
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
Octreotide
- NCT00842348Phase 3Completed
Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour
Lanreotide
- NCT00902265N/ACompleted
Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)
Desmopressin
- NCT00806468Phase 4Terminated
Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease
Desmopressin
- NCT00627406Phase 4Completed
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Gonadorelin
- NCT00805935Phase 4Completed
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
Gonadorelin
- NCT01311037N/AUnknown
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
Gonadorelin
- NCT00835848Phase 4Completed
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
Exenatide